Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
D000293:Adolescent; D000374:Aggression / Q000523:psychology; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology*; D002998:Clonazepam / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004493:Education; D005190:Family; D018757:GABA Modulators / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007508:Irritable Mood; D008094:Lithium / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D010879:Piperazines / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012725:Sexual Behavior; D013844:Thiazoles / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018757:GABA Modulators; D010879:Piperazines; D013844:Thiazoles; D002998:Clonazepam; D014635:Valproic Acid; C092292:ziprasidone; D008094:Lithium; D006220:Haloperidol; D008140:Lorazepam